相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Purinergic signaling in diabetes and metabolism
Shanu Jain et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Nitrogen-Walk Approach to Explore Bioisosteric Replacements in a Series of Potent A2B Adenosine Receptor Antagonists
Ana Mallo-Abreu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
One molecule two goals: A selective P-glycoprotein modulator increases drug transport across gastro-intestinal barrier and recovers doxorubicin toxicity in multidrug resistant cancer cells
Marialessandra Contino et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
PBF-680, an oral A1 adenosine receptor antagonist, inhibits the late allergic response (LAR) in mild-to-moderate atopic asthmatics: a Phase-IIa trial
David Ramos-Barbon et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
Kenneth A. Jacobson et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Understanding Ligand Binding Selectivity in a Prototypical GPCR Family
Giulio Mattedi et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)
QligFEP: an automated workflow for small molecule free energy calculations in Q
Willem Jespers et al.
JOURNAL OF CHEMINFORMATICS (2019)
Research progress on adenosine in central nervous system diseases
Ying-Jiao Liu et al.
CNS NEUROSCIENCE & THERAPEUTICS (2019)
Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives
Pran K. Deb et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
Design, synthesis and biological evaluation of stereo- and regioisomers of amino aryl esters as multidrug resistance (MDR) reversers
Elisabetta Teodori et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Trifluorinated Pyrimidine-Based A2B Antagonists: Optimization and Evidence of Stereospecific Recognition
Ana Mallo-Abreu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Design, Biological Evaluation, and Molecular Modeling of Tetrahydroisoquinoline Derivatives: Discovery of A Potent P-Glycoprotein Ligand Overcoming Multidrug Resistance in Cancer Stem Cells
Chiara Riganti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
The cholinergic system in the pathophysiology and treatment of Alzheimer's disease
Harald Hampel et al.
BRAIN (2018)
PHARMACOLOGY OF ADENOSINE RECEPTORS: THE STATE OF THE ART
Pier Andrea Borea et al.
PHYSIOLOGICAL REVIEWS (2018)
Structural Mapping of Adenosine Receptor Mutations: Ligand Binding and Signaling Mechanisms
Willem Jespers et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Structure of the adenosine-bound human adenosine A(1) receptor-G(i) complex
Christopher J. Draper-Joyce et al.
NATURE (2018)
Targeting adenosine A2A receptor antagonism for treatment of cancer
Miles Congreve et al.
EXPERT OPINION ON DRUG DISCOVERY (2018)
Q6: A comprehensive toolkit for empirical valence bond and related free energy calculations
Paul Bauer et al.
SOFTWAREX (2018)
Structure-Based Rational Design of Adenosine Receptor Ligands
Hugo Gutierrez-de-Teran et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)
Extracellular purines, purinergic receptors and tumor growth
F. Di Virgilio et al.
ONCOGENE (2017)
Targeting A2 adenosine receptors in cancer
David Allard et al.
IMMUNOLOGY AND CELL BIOLOGY (2017)
Enantiospecific Recognition at the A2B Adenosine Receptor by Alkyl 2-Cyanoimino-4-substituted-6-methyl-1,2,3,4-tetrahydropyrimidine-5-carboxylates
Carlos Carbajales et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Structure-Based Design of Potent and Selective Ligands at the Four Adenosine Receptors
Willem Jespers et al.
MOLECULES (2017)
Structures of Human A1 and A2A Adenosine Receptors with Xanthines Reveal Determinants of Selectivity
Robert K. Y. Cheng et al.
STRUCTURE (2017)
Structure of the Adenosine A1 Receptor Reveals the Basis for Subtype Selectivity
Alisa Glukhova et al.
CELL (2017)
Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist Chemotypes
Abdelaziz El Maatougui et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
How does adenosine control neuronal dysfunction and neurodegeneration?
Rodrigo A. Cunha
JOURNAL OF NEUROCHEMISTRY (2016)
Improved Peptide and Protein Torsional Energetics with the OPLS-AA Force Field
Michael J. Robertson et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)
Accurate and Reliable Prediction of Relative Ligand Binding Potency in Prospective Drug Discovery by Way of a Modern Free-Energy Calculation Protocol and Force Field
Lingle Wang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Basal adenosine modulates the functional properties of AMPA receptors in mouse hippocampal neurons through the activation of A1R A2AR and A3R
Silvia Di Angelantonio et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: A review
Marla Rivera-Oliver et al.
LIFE SCIENCES (2014)
Characterization of the dynamic events of GPCRs by automated computational simulations
Hugo Gutierrez-de-Teran et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2013)
Discovery of 3,4-Dihydropyrimidin-2(1H)-ones As a Novel Class of Potent and Selective A2B Adenosine Receptor Antagonists
Abel Crespo et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Three-Component Assembly of Structurally Diverse 2-Aminopyrimidine-5-carbonitriles
Cristina Val et al.
ACS COMBINATORIAL SCIENCE (2013)
Recent developments in adenosine receptor ligands and their potential as novel drugs
Christa E. Mueller et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2011)
Pyrimidine Derivatives as Potent and Selective A3 Adenosine Receptor Antagonists
Vicente Yaziji et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors-An Update
Bertil B. Fredholm et al.
PHARMACOLOGICAL REVIEWS (2011)
2-Amino-5-benzoyl-4-phenylthiazoles: Development of potent and selective adenosine A1 receptor antagonists
Anja B. Scheiff et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Perspectives of P-Glycoprotein Modulating Agents in Oncology and Neurodegenerative Diseases: Pharmaceutical, Biological, and Diagnostic Potentials
Nicola Antonio Colabufo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
An automated liquid chromatography-mass spectrometry process to determine metabolic stability half-life and intrinsic clearance of drug candidates by substrate depletion
Colleen A. McNaney et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2008)
A new generation of adenosine receptor antagonists:: From di- to trisubstituted aminopyrimidines
Jacobus P. D. van Veldhoven et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation
Berk Hess et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2008)
The adenosine A1 receptor antagonist SLV320 reduces myocardial fibrosis in rats with 5/6 nephrectomy without affecting blood pressure
P. Kalk et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Potent and orally bioavailable 8-bicyclo[2.2.2]octylxanthines as adenosine A1 receptor antagonists
William F. Kiesman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Improving potency, selectivity, and water solubility of adenosine A1 receptor antagonists:: Xanthines modified at position 3 and related pyrimido[1,2,3-cd]purinediones
Stefanie Weyler et al.
CHEMMEDCHEM (2006)
Adenosine in the airways: Implications and applications
L Spicuzza et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Progress in the pursuit of therapeutic adenosine receptor antagonists
S Moro et al.
MEDICINAL RESEARCH REVIEWS (2006)
A novel A1 adenosine receptor antagonist, L-97-1 [3-[2-(4-aminophenyl)-ethyl]-8-benzyl-7-{2-ethyl-(2-hydroxy-ethyl)amino]-ethyl}-1-propyl-3,7-dihydro-purine-2,6-dione], reduces allergic responses to house dust mite in an allergic rabbit model of asthma
PCM Obiefuna et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
The discovery and synthesis of novel adenosine receptor (A2A) antagonists
JJ Matasi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening
TA Halgren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Pharmacological characterization of FR194921, a new potent, selective, and orally active antagonist for central adenosine A1 receptors
T Maemoto et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2004)
Pharmacology and therapeutic applications of A(1) adenosine receptor ligands
AK Dhalla et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2003)
Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides
GA Kaminski et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2001)
分享论文
